Bioequivalence and Bioavailability Forum 00:00 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

EMA: 5 product-specific guidances adopted [BE/BA News]

posted by Helmut Homepage - Vienna, Austria, 2018-08-03 16:52  - Posting: # 19133
Views: 962

Dear all,

today the EMA published another set of product-specific guidances (adopted by the CHMP 26 July, effective with 2 February 2019):
  1. Agomelatine tablet 25 mg
  2. Posaconazole gastro-resistant tablet 100 mg
  3. Ledipasvir/sofosbuvir film-coated tablet 90 mg/400 mg
  4. Cholic acid capsules 50 mg and 250 mg
  5. Vismodegib hard capsule 150 mg

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,931 posts in 4,039 threads, 1,285 registered users;
online 6 (0 registered, 6 guests [including 4 identified bots]).

A drug is not bad. A drug is a chemical compound.
The problem comes in when people who take drugs treat them
like a license to behave like an asshole.    Frank Zappa

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed